186) ed the characteristics and outcomes of 49 patients with AHA diagnosed in our center |
187) ive and safe to control acute bleeding in patients with AHA. |
188) and during anakinra administration among patients with BD were evaluated. |
189) Thirteen patients with BD were treated with session |
190) A convenient sample of 153 patients with CAD was recruited from the c |
191) port and selected sociodemographics among patients with CAD. |
192) inary NGAL as a predictor of CV events in patients with CKD. |
193) ies for arterial stiffness attenuation in patients with CKD. |
194) e that the decreased vitD levels, seen in patients with CVD and chronic immunopathol |
195) ascular and systemic inflammation seen in patients with CVD. |
196) IgG in old age or low antithrombin level patients with DIC with old age or low anti |
197) automated chemiluminescence system in 118 patients with DIC. |
198) revalence and clinical characteristics of patients with LGV since 2007 when active c |
199) Medical records of all patients with LGV were reviewed. |
200) The subjects were patients with MFS (n = 40) who attended th |
201) While it is known that patients with MFS are at high risk of dent |
202) , and medication use in a large cohort of patients with NE. |
203) We identified 115 patients with NE. |
204) We classified 355 patients with NSTE-ACS according to the ad |
205) s not associated with adverse outcomes in patients with NSTE-ACS treated with dual a |
206) heterozygous state was present in only 3 patients with SS disease and was absent in |
207) ors for a hypercoagulable state in Indian patients with SS disease. |
208) ter peaking (slope) were compared between patients with SSc and controls.Compared to |
209) ver, did not differ significantly between patients with SSc and controls.Unaffected |
210) ute Coronary Events (GRACE) risk score in patients with ST-segment elevated myocardi |
211) artery (IRA) and the clinical outcomes in patients with ST-segment elevation myocard |
212) lar elastic bandage can be safely used in patients with VLUs requiring frequent dres |
213) ffective compression dressing regimen for patients with VLUs who require changing th |
214) We retrospectively enrolled 77 patients with VTE (distal deep vein thromb |
215) d it is useful for risk stratification in patients with VTE. |
216) phy to assess tumor vascularity except in patients with angina or those older than 4 |
217) y (VH) intravascular ultrasound (IVUS) in patients with angina pectoris (AP). |
218) Patients with antiheparin/PF4 IgG had a hi |
add keyword